ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(24 sites)
Australia
The George Institute for Global Health, Sydney, Barangaroo Royal Prince Alfred Hospital, Sydney, New South Wales Monash University (Box Hill), Melbourne, Victoria Canada
University of Calgary, Calgary, Alberta Medicine Hat Regional Hospital, Medicine Hat, Alberta Red Deer Regional Hospital, Red Deer, Alberta University of Alberta, Edmonton, A Kelowna Regional Hospital, Kelowna, British Columbia Royal Columbian Hospital, New Westminster, British Columbia University of British Columbia, Vancouver, British Columbia Brandon Regional Hospital, Brandon, Manitoba University of Manitoba - Winnipeg Health Science Centre, Winnipeg, Manitoba Queen Elizabeth II Health Science Center (Halifax), Halifax, Nova Scotia Health Sciences North Horizon Sante-Nord, Greater Sudbury, Ontario McMaster University Hamilton Health Sciences Centre, Hamilton, Ontario Kingston General Hospital, Kingston, Ontario Lawson Health Research Institute- London, London, Ontario University of Ottawa, Ottawa, Ontario St. Michael's Hospital, Toronto, Ontario Sunnybrook Health Science Centre, Toronto, Ontario Queen Elizabeth Hospital (PEI), Charlottetown, Prince Edward Island Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec CIUSSS de l'Estrie - CHUS Fleurimont Hôpital (Sherbrooke), Sherbrooke, Quebec Royal University Hospital, Saskatoon, Saskatchewan Age range
18 Years and older
Last updated September 2025